A Phase 2, Randomized, Double-blind,Placebo-controlled, 6-Week, Parallel-design Study of the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy | Neuromuscular Program | Dartmouth-Hitchcock
Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
A Phase 2, Randomized, Double-blind,Placebo-controlled, 6-Week, Parallel-design Study of the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy
Principal Investigator (?)
Study Number
F17140
Summary
This is a Phase 2, randomized, double-blind, placebo-controlled, parallel-group, multicenter study evaluating the efficacy of VX-150 for the treatment of pain caused by small fiber neuropathy 
Phase (?)
Phase III
Sponsor (?)
Contact

Thomas Palladino

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0